Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.440
-0.060 (-4.00%)
At close: Oct 29, 2024, 4:00 PM
1.560
+0.120 (8.33%)
After-hours: Oct 29, 2024, 5:56 PM EDT
Chemomab Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -15 | -24.22 | -27.65 | -12.48 | -5.95 | -6.78 | |
| Depreciation & Amortization | 0.06 | 0.07 | 0.06 | 0.03 | 0.02 | 0.02 | |
| Stock-Based Compensation | 0.72 | 1.49 | 3.21 | 2.02 | 0.13 | 0.14 | |
| Other Operating Activities | - | - | - | - | - | -0 | |
| Change in Accounts Receivable | 0.56 | 0.9 | -0.06 | -2.06 | -0.1 | 0.04 | |
| Change in Accounts Payable | -1.23 | -1.17 | 0.35 | 1.18 | 0.07 | -0.24 | |
| Change in Other Net Operating Assets | -1.25 | -0.68 | 3.72 | -1.07 | 0.59 | 0.2 | |
| Operating Cash Flow | -16.13 | -23.61 | -20.37 | -12.37 | -5.24 | -6.63 | |
| Capital Expenditures | - | -0 | -0.07 | -0.24 | -0.04 | -0 | |
| Sale of Property, Plant & Equipment | - | - | - | 1 | - | - | |
| Investment in Securities | 8.52 | 15.88 | 19.6 | -45.95 | -0.02 | - | |
| Other Investing Activities | - | - | - | 0 | - | - | |
| Investing Cash Flow | 8.52 | 15.88 | 19.53 | -45.19 | -0.06 | -0 | |
| Issuance of Common Stock | 2.27 | 3.5 | 0.41 | 58.65 | 1.25 | 0.09 | |
| Repurchase of Common Stock | - | - | -1.22 | - | - | - | |
| Other Financing Activities | - | - | - | 2.43 | - | - | |
| Financing Cash Flow | 2.27 | 3.5 | -0.81 | 61.07 | 4.75 | 14.08 | |
| Net Cash Flow | -5.35 | -4.23 | -1.65 | 3.51 | -0.55 | 7.45 | |
| Free Cash Flow | -16.13 | -23.61 | -20.44 | -12.61 | -5.28 | -6.63 | |
| Free Cash Flow Per Share | -1.21 | -2.01 | -1.80 | -1.22 | -0.77 | - | |
| Cash Income Tax Paid | - | -0.19 | -0.35 | - | - | - | |
| Levered Free Cash Flow | -11.36 | -15.49 | -10.87 | -6.07 | -2.56 | -4.59 | |
| Unlevered Free Cash Flow | -11.36 | -15.49 | -10.87 | -6 | -2.56 | -4.58 | |
| Change in Net Working Capital | 2.13 | 1.13 | -3.77 | 0.09 | -1.06 | 0.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.